CADTH

From HLWIKI Canada
Jump to: navigation, search
Are you interested in contributing to HLWIKI International? contact: dean.giustini@ubc.ca

To browse other articles on a range of HSL topics, see the A-Z index.

Contents

Last Update

This entry is out of date, and will not be updated, June 2017

Introduction

See also Grey literature | Health Technology Assessment International (HTAi) | Network meta-analysis | Systematic reviews | Systematic review searching

The Canadian Agency for Drugs and Technologies in Health (CADTH) / L'Agence canadienne des médicaments et des technologies de la santé (ACMTS) is a national not-for-profit producer and broker of health technology assessments and supporter of informed healthcare decision-making. To that end, CADTH provides health care decision-makers and practitioners with the evidence, analysis, advice and recommendations they need to make informed decisions. CADTH is funded jointly by Canada’s federal, provincial and territorial governments but operates independently to deliver timely, evidence-based information to health leaders about the effectiveness and efficiency of health technologies including drugs, medical devices, medical/surgical procedures and diagnostic tests. Through its wide variety of services and products, CADTH delivers information that Canada’s health care decision-makers can rely on and which is relevant to the Canadian context. CADTH is funded by the federal, provincial and territorial governments, with the exception of Quebec. CADTH's main offices are located in Ottawa, Ontario with affiliate offices in Edmonton, and Toronto. Individual liaison officers are located in most provinces.

CADTH's information providing role

To support the effective management of drugs and other health technologies in Canada, CADTH provides a range of products and services, including:

  • Formulary Reviews (Common Drug Review): Objective, rigorous reviews of the clinical, cost-effectiveness, and patient evidence for drugs and formulary listing recommendations provided Canada’s publicly funded drug plans (except Quebec).
  • Optimal Use Projects: Comprehensive assessments of drugs and other health technologies identified as priorities by member jurisdictions.
  • Rapid Responses: Information tailored to meet urgent jurisdictional needs, to inform policy and practice decisions.
  • Environmental and Horizon Scans: Alerts about new and emerging health technologies that support effective planning within the health care system.

It is important to note that many of the reports published by CADTH involve comprehensive search protocols. These protocols are widely-shared and inform the search activities of health librarians in other jurisdictions within the Canadian health system. Two popular documents in this regard are Finding the evidence: literature searching tools in support of systematic reviews and Grey Matters: a practical search tool for evidence-based medicine.

Health Technology Assessment (HTA)

Health technology assessment (HTA) is a multidisciplinary field of policy analysis. It covers the medical, social, ethical and economic implications of development, diffusion and use of health technology. Health technology is defined as prevention and rehabilitation, vaccines, pharmaceuticals and devices, medical and surgical procedures, and the systems within which health is protected and maintained. ~ Cleemput, Van Den Bruel, Kohn, Vlayen, Vinck and Thiry et al, 2007

CADTH's Top Ten Downloads

Every month, CADTH publishes a list of the most frequently downloaded reports from its website. Click here to see the current list.

Key websites

See also

References

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox